Key result
AT2 receptor stimulation inhibits insulin-induced cell proliferation in vitro by trans-inactivating insulin receptor kinase.
The study demonstrates a novel mechanism of negative cross-talk where AT2 receptor stimulation functionally trans-inactivates insulin receptor kinase.
Does not inform therapy; leaves open in vivo relevance of AT2-insulin receptor cross-talk.
The present study demonstrates negative intracellular cross-talk between angiotensin II type 2 (AT2) and insulin receptors. AT2 receptor stimulation leads to inhibition of insulin-induced extracellular signal-regulated protein kinase (ERK2) activity and cell proliferation in transfected Chinese hamster ovary (CHO-hAT2) cells. We show that AT2 receptor interferes at the initial step of insulin signaling cascade, by impairing tyrosine phosphorylation of the insulin receptor (IR)β -chain. AT2-mediated inhibition of IR phosphorylation is insensitive to pertussis toxin and is also detected in neuroblastoma N1E-115 and pancreatic acinar AR42J cells that express endogenous receptors. We present evidence that AT2 receptor inhibits the autophosphorylating tyrosine kinase activity of IR, with no significant effect on insulin binding properties. AT2-mediated inactivation of IR does not mainly involve tyrosine dephosphorylation by vanadate-sensitive tyrosine phosphatases nor serine/threonine phosphorylation by protein kinase C. As a consequence of IR inactivation, AT2 receptor inhibits tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) and signal-regulatory protein (SIRPα1) and prevents subsequent association of both IRS-1 and SIRPα1 with Src homology 2 (SH2)-containing tyrosine phosphatase SHP-2. Our results thus demonstrate functional trans-inactivation of IR kinase by G protein-coupled AT2 receptor, illustrating a novel mode of negative communication between two families of membrane receptors.
No takes yet. Share an insight, caveat, or question.
N. Elbaz (2000) studied this question. Angiotensin II type 2 (AT2) receptor stimulation was evaluated on Insulin receptor kinase activity and insulin-induced ERK2 activity. Angiotensin II type 2 receptor stimulation functionally trans-inactivates the insulin receptor kinase, inhibiting insulin-induced ERK2 activity and cell proliferation in vitro.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: